Hogan Lovells has advised Gilde Healthcare on the deal. Tromp Medical, Europe’s largest independent medical imaging sales and service organization, has attracted Gilde Healthcare as new...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Gilde Healthcare and Eetgemak on the deal. Eetgemak Group, a portfolio company of Gilde Healthcare, has acquired TotaalVERS TotaalVERS TotaalVERS is an integrated...
You must be a Standard 1 Year member to access this content.
Schellenberg Wittmer advised Gilde Healthcare on the deal. Gilde Healthcare’s Private Equity Fund (Gilde Healthcare), a specialized healthcare investor, completed the acquisition of a majority of the...
You must be a Standard 1 Year member to access this content.
Goodwin has advised Gilde Healthcare on the financing of the acquisition of Koscher & Würtz. King & Wood Mallesons advised the shareholders of Koscher & Würtz...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised the syndicate of investors on the deal. Tagworks Pharmaceuticals BV announced a $65 million Series A financing led by Ysios Capital and Gilde Healthcare...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised specialised healthcare investor Gilde Healthcare on the deal. Gilde Healthcare, a specialized healthcare investor, today announces its intention to acquire Sanquin Reagents from...
You must be a Standard 1 Year member to access this content.
Greenberg Traurig has advised Gilde Healthcare on the deal. Gilde Healthcare, a European private equity fund specializing in healthcare investments, announced the acquisition of a majority stake...
You must be a Standard 1 Year member to access this content.
Greenberg Traurig advised Gilde Healthcare on the deal. Gilde Healthcare, a specialist healthcare private equity fund, announced its acquisition of EUROPIN Group, which is headquartered in Heidelberg,...
You must be a Standard 1 Year member to access this content.
Arthur Cox advised Gilde Healthcare and Lightstone Ventures on the deal. Gilde Healthcare and Lightstone Ventures led a €30 million Series A investment round in ProVerum...
You must be a Standard 1 Year member to access this content.
King & Wood Mallesons, Ehlers & Partner and Shearman & Sterling assisted the Investor consortium on the acquisition. CMS advised the Regneri family as the sellers....
You must be a Standard 1 Year member to access this content.
Greenberg Traurig, LLP advised Gilde Healthcare on the deal, while Heuking Kühn Lüer Wojtek and bnt Neupert Zamorska & Partnerzy Sp.J advised Acti-Med AG. Gilde Healthcare,...
You must be a Standard 1 Year member to access this content.
Rutgers & Posch advised the shareholders of Tandarts Today on the deal. Maverick Advocaten advised Gilde Healthcare. The shareholders of Tandarts Today completed the sale of...
You must be a Standard 1 Year member to access this content.
